Clinical trial Recruiting at 1 site Observational

Ventilation settings and acid-base balance after cardiac arrest or cardiogenic shock

Official title: Evaluation of Acid-base Disorders and Ventilation Settings in Cardiogenic Shock and Post-cardiac Arrest Patients: Comparison With VentilO Algorithm

Run by Laval University · NCT07484828 · Data updated 2026-11-12

This study tests how different initial ventilator settings align with a decision-support algorithm to see if acid-base imbalances can be reduced in adults with cardiac arrest or cardiogenic shock on mechanical ventilation.

More Mechanical Ventilation trials

Quick facts

Study typeObservational
SexAll
Enrollment100 (estimated)
SponsorLaval University
Academic / other
Locations1 site (Québec, Quebec)
StatusRecruiting
StartedJune 9, 2026
Main results expectedJune 2027
Study endsDecember 2027
Registry record updatedNovember 5, 2026
Trial IDNCT07484828 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18 years and older) who are on endotracheal mechanical ventilation for post-cardiac arrest or cardiogenic shock and have blood gas data available within four hours of admission.

Probably not a fit

Patients lacking complete records (anthropometric data or initial humidification data) or those stabilized after transfer or after initial respiratory parameter adjustments may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational analysis will retrospectively examine 100 adult patients admitted to a cardiac care unit, half after cardiac arrest and half with cardiogenic shock, who required mechanical ventilation. It will describe how often acid-base disorders occur and characterize their features. The study will compare clinicians’ initial ventilator settings with recommendations from the VentilO decision-support algorithm and assess potential effects on first blood gas results after admission. Data are drawn from the Laval University system at the Université Laval affiliated center in Québec, focusing on records available within four hours of admission. The results may inform how algorithm-guided ventilation could influence early management in this population.

Why it matters

Potential benefit: If successful, aligning ventilation settings with algorithm guidance could reduce acid-base disturbances and improve early respiratory management for these high-risk patients.

How similar studies have gone: Prior work in algorithm-guided ventilation has shown promise in other critical care populations, but this specific VentilO comparison in post-arrest and cardiogenic shock patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult (Age \>=18 years old)
* Under mechanical ventilation with endotracheal tube for :

post cardiac arrest or cardiogenic shock

\- Bood gases result availability up to 4 hours after coronary unit admission

Exclusion Criteria:

* Lack of patient anthropometric data (height and weight) available in the patient record
* No information in the record regarding the data on the humidification systems used at the time of the first blood gas test upon admission to the coronary care unit.
* Patient stabilzed in other hospital before coronary unit admission or adjustment of respiratory parameters after a blood gas test.

Where it's running

  • Insitut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval
    Québec, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.